Clinical Trial Update: HFNO VERSUS BIPAP IN PREECLAMPTIC PATIENTS WITH ACUTE HYPOXAEMIC RESPIRATORY FAILURE [NA]

View source ↗

Summary

This is a completed clinical trial comparing high-flow nasal oxygen (HFNO) with BiPAP in preeclamptic patients with acute hypoxemic respiratory failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia
• Respiratory Failure

Snippet

Sponsor: Alexandria University | Conditions: HFNO vs BIPAP, Preeclamptic Acute Hypoxaemic Respiratory Failure | NA | Status: COMPLETED